Average Co-Inventor Count = 3.96
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (18 from 2,198 patents)
2. Other (3 from 832,843 patents)
3. Glaxosmithkline LLC (2 from 356 patents)
16 patents:
1. 7982005 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
2. 7807793 - Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
3. 7399837 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
4. 6998124 - Erythropoietin receptor antibodies
5. 6946130 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
6. 6706487 - Monoclonal antibody and the method of using the antibody
7. 6376653 - Tie2 antagonist antibodies
8. 6365154 - Tie2 agonist antibodies
9. 6358704 - M protein
10. 6129913 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated
11. 5928904 - DNA encoding recombinant IL4 antibodies useful in treatment of IL4
12. 5914110 - Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
13. 5882896 - M protein
14. 5851525 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated
15. 5693323 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated